{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:14:06Z","timestamp":1769631246703,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10096-020-04147-5","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T03:02:44Z","timestamp":1611630164000},"page":"1539-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-8346","authenticated-orcid":false,"given":"Sehnaz","family":"Alp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolunay","family":"Gulmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u0131za Can","family":"Kardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahit","family":"Tas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caglayan Merve","family":"Ayaz-Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"4147_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133\u2013163","journal-title":"Clin Microbiol Rev"},{"key":"4147_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2217\/17460913.3.4.463","volume":"3","author":"A Chang","year":"2008","unstructured":"Chang A, Neofytos D, Horn D (2008) Candidaemia in the 21st century. Future Microbiol 3:463\u2013472","journal-title":"Future Microbiol"},{"key":"4147_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10096-003-0890-x","volume":"22","author":"H Alonso-Valle","year":"2003","unstructured":"Alonso-Valle H, Acha O, Garcia-Palomo JD, Fari\u00f1as-Alvarez C, Fern\u00e1ndez-Mazarrasa C, Fari\u00f1as MC (2003) Candidaemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 22:254\u2013257","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4147_CR4","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640\u20133645","journal-title":"Antimicrob Agents Chemother"},{"key":"4147_CR5","first-page":"1942","volume":"21","author":"DS Jung","year":"2015","unstructured":"Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP (2015) Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerg Infect Dis 21:1942\u20131950","journal-title":"Emerg Infect Dis"},{"key":"4147_CR6","doi-asserted-by":"publisher","first-page":"15239","DOI":"10.1038\/s41598-018-33662-x","volume":"8","author":"MH Tsai","year":"2018","unstructured":"Tsai MH, Hsu JF, Yang LY et al (2018) Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes. Sci Rep 8:15239","journal-title":"Sci Rep"},{"key":"4147_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jmii.2017.08.007","volume":"52","author":"WL Liu","year":"2019","unstructured":"Liu WL, Lai CC, Li MC et al (2019) Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014. J Microbiol Immunol Infect 52:612\u2013619","journal-title":"J Microbiol Immunol Infect"},{"key":"4147_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1469-0691.2009.02821.x","volume":"15","author":"SCA Chen","year":"2009","unstructured":"Chen SCA, Marriott D, Playford EG et al (2009) Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 15:662\u2013669","journal-title":"Clin Microbiol Infect"},{"key":"4147_CR9","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1128\/JCM.00131-14","volume":"52","author":"SF Dufresne","year":"2014","unstructured":"Dufresne SF, Marr KA, Sydnor E et al (2014) Epidemiology of Candida kefyr in patients with hematologic malignancies. J Clin Microbiol 52:1830\u20131837","journal-title":"J Clin Microbiol"},{"key":"4147_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13693780801968571","volume":"46","author":"BJ Atkinson","year":"2008","unstructured":"Atkinson BJ, Lewis RE, Kontoyiannis DP (2008) Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 46:541\u2013546","journal-title":"Med Mycol"},{"key":"4147_CR11","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1128\/JCM.00356-06","volume":"44","author":"C Girmenia","year":"2006","unstructured":"Girmenia C, Pizzarelli G, Cristini F et al (2006) Candida guilliermondii fungemia in patients with hematologic malignancies. J Clin Microbiol 44:2458\u20132464","journal-title":"J Clin Microbiol"},{"key":"4147_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.diagmicrobio.2007.07.014","volume":"60","author":"J Pem\u00e1n","year":"2008","unstructured":"Pem\u00e1n J, Bosch M, Cant\u00f3n E et al (2008) Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period. Diagn Microbiol Infect Dis 60:109\u2013112","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4147_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1439-0507.2010.01960.x","volume":"54","author":"V Savini","year":"2011","unstructured":"Savini V, Catavitello C, Onofrillo D et al (2011) What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast. Mycoses 54:434\u2013441","journal-title":"Mycoses"},{"key":"4147_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1086\/318473","volume":"32","author":"A Minari","year":"2001","unstructured":"Minari A, Hachem R, Raad I (2001) Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32:186\u2013190","journal-title":"Clin Infect Dis"},{"key":"4147_CR15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","volume":"62","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Hoenigl M, Lass-Fl\u00f6rl C et al (2019) Defining breakthrough invasive fungal infection-position paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology. Mycoses 62:716\u2013729","journal-title":"Mycoses"},{"key":"4147_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/9781555816605","volume-title":"Medically important fungi: a guide to identification","author":"DH Larone","year":"2011","unstructured":"Larone DH (2011) Medically important fungi: a guide to identification, 5th edn. ASM Press, Washington D.C.","edition":"5"},{"key":"4147_CR17","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne"},{"key":"4147_CR18","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2012) Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4. Clinical and Laboratory Standards Institute, Wayne"},{"key":"4147_CR19","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Diekema DJ (2012) Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010\u20132012. J Clin Microbiol 50:2846\u20132856","journal-title":"J Clin Microbiol"},{"key":"4147_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","volume":"13","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D, CLSI Subcommittee for Antifungal Susceptibility Testing (2010) Wild-type MIC distributions, epidemiological cut-off values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 13:180\u2013195","journal-title":"Drug Resist Updat"},{"key":"4147_CR21","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/AAC.01451-13","volume":"57","author":"RK Shields","year":"2013","unstructured":"Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ (2013) Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance. Antimicrob Agents Chemother 57:6361\u20136365","journal-title":"Antimicrob Agents Chemother"},{"key":"4147_CR22","first-page":"1139e43","volume":"44","author":"M Sutcu","year":"2016","unstructured":"Sutcu M, Salman N, Akturk H et al (2016) Epidemiologic and microbiologic evaluation of nosocomial infections associated with Candida spp. in children: a multicenter study from Istanbul, Turkey. Am J Infect Control 44:1139e43","journal-title":"Am J Infect Control"},{"key":"4147_CR23","doi-asserted-by":"publisher","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","volume":"11","author":"AM Doi","year":"2016","unstructured":"Doi AM, Pignatari AC, Edmond MB et al (2016) Epidemiology and microbiologic characterization of nosocomial candidemia from a brazilian national surveillance program. PLoS One 11:e0146909","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"4147_CR24","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN (2019) Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997-2016. Open Forum Infect Dis 6(Suppl 1):S79\u2013S94","journal-title":"Open Forum Infect Dis"},{"key":"4147_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.mycmed.2019.03.002","volume":"29","author":"A Ludwig","year":"2019","unstructured":"Ludwig A, de Jesus FPK, Dutra V, C\u00e2ndido SL, Alves SH, Santurio JM (2019) Susceptibility profile of Candida rugosa (Diutina rugosa) against antifungals and compounds of essential oils. J Mycol Med 29:154\u2013157","journal-title":"J Mycol Med"},{"key":"4147_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46:120\u2013128","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04147-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04147-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04147-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T04:48:34Z","timestamp":1697690914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04147-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04147-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"22 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study protocol was approved by the Clinical Research Ethics Committee of Hacettepe University (No: GO 17\/698-03).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was not required because of the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}